Dr. Petrocchi Federica
Medical activity: Works at IRCCS G.B. Bietti in the offices Via Livenza, 3 and Via di santo Stefano Rotondo 6, at Presidio Ospedaliero Britannico, Rome
linkedin: Federica Petrocchi
2005: High school diploma, “T. Mamiani ” Lyceum, Rome.
2008: Bachelor Degree with Honors in Orthoptics and Ophthalmology Assistance, the Catholic University
of the Sacred Heart in Rome.
2008-2010: Attendance at the Orthoptics Clinic of the Universitary Hospital “A. Gemelli “of Rome
2010-2017: Contractor as orthoptist and clinical researcher at the Neurophysiology of Vision and Neurophthalmology Research Unit, IRCCS “G.B.” Bietti Foundation, Rome.
2017-current: Full time position as orthoptist and clinical researcher at the Neurophysiology of Vision and Neurophthalmology Research Unit, IRCCS “G.B.” Bietti Foundation, Rome.
2014: Paper Presentation : “The orthoptist’s point of view: alternate syndromes” at the regional AIOrAO Campania course entitled NEUROFTALMOLOGICAL DISORDERS: DIAGNOSIS AND TREATMENT, approved by Agenas.
2015: Paper Presentation : “Evaluation of visual acuity: 3-6 years of age” at the VII regional AIOrAO Lazio meeting titled EVALUATION AND PROPOSAL OF VISUAL TRAINING IN CHILDREN WITH ALTERATIONS OF SACCADIC MOVEMENTS AND FLUID TRACKING, approved by Agenas.
2017: Paper Presentation: “Usage of the visual kinetic field in the diagnosis of glaucoma” at the Symposium of Nurses and Orthoptists of the XIII National Meeting of the Italian Society of Glaucoma (SIGLA).
2017: Paper Presentation: “Paresis and paralysis of extraocular muscles: diagnosis and treatment” at the regional AIOrAO Campania course entitled THE SKILLS OF THE ORTHOPTIST IN GERIATRIC PATIENTS: FROM DIAGNOSTIC SUPPORT TO REHABILITATION, approved by Agenas.
2008 – current: AIOrAO member (Italian Association of Orthoptists and Ophthalmology Assistants).
2014 – current: Secretary of the Regional Direction of AIOrAO Lazio.
2014-2017:
Institutional Ministerial Project: Morphofunctional visual pathways evaluation in multiple sclerosis: possible identification of neurodegenerative biomarkers. Project Code: RF-2011-02347280. Principal Investigator: Prof. Vincenzo Parisi
2016:
No profit clinical study (Bietti Foundation – IRCCS NEU-03-2016) Neuroprotection and neuroprotentation in a model of optic nerve neurodegeneration (non-arteritic ischemic optic neuritis): study of morpho-functional variations in relation to treatment with citicoline in oral solution. Principal Investigator: Prof. Vincenzo Parisi
2016:
Clinical observational study (5×1000 funds of the Ministry of Health, year 2013, promoted by Bietti Foundation – IRCCS NEU-03-2016) Functional evaluation of retinal involvement in post-neuritic neurodegenerative processes in patients with multiple sclerosis. Principal Investigator: Prof. Vincenzo Parisi and Dr. Lucia Ziccardi
2016:
Observational study SNT-CRS-002 promoted by Santhera Pharmaceuticals Historical case record of visual acuity from patients with Leber’s Hereditary Optic Neuropathy (LHON). Principal Investigator: Prof. Vincenzo Parisi
2014-2015:
Clinical study (5×1000 funds of the Ministry of Health, year 2011, promoted by Bietti Foundation – IRCCS NEU-01-2014) “Clinical and functional characterization of ocular rare diseases with genetic transmission. Phenotype-genotype correlation “ Principal Investigator: Prof. Vincenzo Parisi and Dr. Lucia Ziccardi
2011:
AIFA (Italian Agency for Drugs) clinical study (promoted by Bietti Foundation – IRCCS NEU-08-2011)
Evaluation of the neuroprotective activity of Minocycline as adjuvant therapy for stabilization of visual function in patients with glaucoma. Principal Investigator: Prof. Vincenzo Parisi.
2013: Clinical sponsored study (DOMPE ‘NGF0113 “)
“A phase Ib / II, multicenter, randomized, double-masked, vehicle controlled, parallel group, dose ranging study with a 24 week follow-up period to evaluate the safety and potential efficacy of two doses (60 and 180 μg / ml) of recombinant human nerve growth factor (rhNGF) eye drops solution versus vehicle in patients with typical retinitis pigmentosa (RP) “. The study involves the administration of rhNGF eye drops (recombinant human nerve growth factor) in patients suffering from an orphan disease called cures called retinitis pigmentosa. Principal Investigator: Prof. Vincenzo Parisi.
2013: LHON Historical Case Record Survey promoted by AIBILI (EVICr.net). Principal Investigator: Prof. Vincenzo Parisi
2012-2013: Sponsored Study (SIGMA TAU ST200-ODU-09-01)
“Effects of administration of L-acetylcarnitine on nerve conduction along the optical pathways in patients suffering from Leber neurotropopathy (Leber Hereditary Optic Neuropathy)”. The study involves the oral administration of an experimental drug L-acetylcarnitine in patients with genetically proven hereditary optic neuropathy. Principal Investigator: Prof. Vincenzo Parisi.
2012: No profit clinical study (promoted by Bietti Foundation – IRCCS NEU-01-2012)
“Evaluation of the potential neuroprotective action of Citicoline in addition to the hypotonic topical therapy for the maintenance and / or improvement of visual functional deficit in patients with glaucoma”. Principal Investigator: Prof. Vincenzo Parisi.
2014: Article published on the report “The alternate syndromes”, presented at the regional AIOrAO course
Campania entitled NEUROPHALMOLOGICAL DISORDERS: DIAGNOSIS AND TREATMENT, on periodical magazine quarterly n.3 / 14 “Prisma”.
